Getein Biotech, Inc reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 384.32 million compared to CNY 570.72 million a year ago. Revenue was CNY 384.32 million compared to CNY 570.72 million a year ago.

Net income was CNY 121.53 million compared to CNY 218.72 million a year ago. Basic earnings per share from continuing operations was CNY 0.24 compared to CNY 0.43 a year ago. Diluted earnings per share from continuing operations was CNY 0.24 compared to CNY 0.43 a year ago.